Could a pill under the tongue prevent dangerous bleeding after birth?
NCT ID NCT06968481
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a sublingual (under the tongue) form of oxytocin to prevent postpartum hemorrhage (severe bleeding) in 330 women having a normal vaginal delivery at full term. The goal is to see if this easy-to-give medicine can keep the uterus firm and limit blood loss to less than 500 ml. Participants will receive one of several doses to find the safest and most effective amount.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST PARTUM HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Africa Center of Excellence for Population Health and Policy
Kano, Nigeria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple kit cut newborn deaths by 25%? a major trial in pakistan aims to find out
- Could a new drug beat the standard for preventing postpartum hemorrhage?
- Could a simple drug cocktail stop postpartum bleeding?
- Finger-Stick and phone app could replace needles for anemia in pregnancy
- New uterine drain shows promise in reducing Post-C-Section bleeding
- New study aims to stop Post-Birth bleeding with smarter drug dosing